PrecivityAD2™ blood test now available in over seven additional countries with primary focus on regions with inadequate PET infrastructureST. LOUIS--(BUSINESS…
Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testingIntroduction of CURECA™, the…
Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the…
NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July…
Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting FREMONT, Calif., July…
Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is…
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology.The minimally…
SHANGHAI--(BUSINESS WIRE)--Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) today announced an exclusive ten-year Promotion Services…
July 10, 2025 16:30 ET | Source: NKGen Biotech, Inc. SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen…
Real-time analytics that empower clinical decision-making and pandemic preparednessGlobal unveiling at ADLM 2025 in Chicago to initiate business partnershipsPowered by AI…